Qube Research & Technologies LTD Bioventus Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Bioventus Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 245,007 shares of BVS stock, worth $2.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245,007
Previous 291,213
15.87%
Holding current value
$2.84 Million
Previous $1.51 Million
7.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BVS
# of Institutions
107Shares Held
39.9MCall Options Held
138KPut Options Held
137K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$151 Million24.48% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$79.2 Million18.67% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.34MShares$61.9 Million2.05% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$27.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$19.2 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $715M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...